Stavudine (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Stavudine drug offered from Mylan Pharmaceuticals Inc.. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | stavudine |
| SUBSTANCE NAME: | STAVUDINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2011-08-24 |
| END MARKETING DATE: | 0000-00-00 |
Stavudine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Stavudine from Mylan Pharmaceuticals Inc. |
| LABELER NAME: | Mylan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 15(mg/1) |
| START MARKETING DATE: | 2011-08-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0378-5040_b18d0296-33fa-447b-9321-8f0a48c8e5e9 |
| PRODUCT NDC: | 0378-5040 |
| APPLICATION NUMBER: | ANDA079069 |
Other STAVUDINE Pharmaceutical Manufacturers / Labelers:
